Genetic testing is indicated in patients with suspected MODY in the presence of a diagnosis of type 1 diabetes mellitus with negative islet antibodies, with preserved beta-cell function and low insulin requirement after a partial remission phase with a positive family history or asymptomatic cases of hyperglycemia detected during routine physical examinations. This evidence concerns the gene INS and diabetes mellitus.